At the Forefront of Drug Discovery and Development: Small to Midsize Biotech/Biopharma Companies are the Leaders of Innovation

Small to midsize biotech/biopharma companies are the leaders of innovation

Read more

Today, the innovators of drug discovery and development are the smaller biotech and biopharma companies around the world. According to a report from HBM Partners AG, in the past several years, more than 60% of new drugs approved originated at small and midsize companies – those outside the 30 largest pharmaceutical firms.
This article is taken from PharmaVoice, April 2017, by Peter Benton.


President and Chief Executive Officer

Want to learn more about Worldwide Clinical Trials?